[Recommendations for treatment of amebiasis. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Working Group].
Hohenschild
S
S
D000328:Adult; D000563:Amebicides / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004748:Entamoeba histolytica / Q000187:drug effects; D004749:Entamoebiasis / Q000175:diagnosis / Q000188:drug therapy*; D005663:Furans / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000175:diagnosis / Q000188:drug therapy*; D008795:Metronidazole / Q000008:administration & dosage* / Q000009:adverse effects
D000563:Amebicides; D000890:Anti-Infective Agents; D005663:Furans; D008795:Metronidazole; C004932:diloxanide furoate
Empfehlungen zur Behandlung der Amöbiasis. Deutsche Gesellschaft für Pädiatrische Infektiologie e. V. (DGPI), Arbeitsgruppe "Parasitologie".